+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Cancer Clinical Trial"

From
From
Oncology-based In-Vivo CRO Global Market Report 2024 - Product Thumbnail Image

Oncology-based In-Vivo CRO Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Immuno-Oncology Clinical Trials Market Report 2023-2033 - Product Thumbnail Image

Immuno-Oncology Clinical Trials Market Report 2023-2033

  • Report
  • September 2023
  • 249 Pages
  • Global
From
From
From
Clinical Trial Imaging Market - Forecasts from 2023 to 2028 - Product Thumbnail Image

Clinical Trial Imaging Market - Forecasts from 2023 to 2028

  • Report
  • December 2023
  • 144 Pages
  • Global
From
From
From
From
From
From
From
Loading Indicator

The Cancer Clinical Trial market within the context of Oncology Drugs is a highly competitive and rapidly evolving space. Companies in this market are focused on developing and testing new treatments for cancer, as well as improving existing treatments. Clinical trials are conducted to evaluate the safety and efficacy of new drugs and treatments, and to determine the best way to use them. Companies in this market are also involved in the development of biomarkers and diagnostics to identify and monitor cancer patients. The Cancer Clinical Trial market is driven by the need for new and improved treatments for cancer, as well as the increasing prevalence of the disease. Companies in this market are investing heavily in research and development to develop new treatments and improve existing ones. Some of the major companies in the Cancer Clinical Trial market include AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Merck, Novartis, Pfizer, and Roche. Show Less Read more